Reaction Details Report a problem with these data
Target
Large envelope protein
Ligand
BDBM520002
Substrate
n/a
Meas. Tech.
Test of Anti HBV Activity In Vitro
EC50
7.00±n/a nM
Citation
 Ren, Q; Liu, X; Huang, J; Zhang, Y; Goldmann, S Dihydropyrimidine compounds and uses thereof in medicine US Patent  US11142527 Publication Date 10/12/2021 
Target
Name:
Large envelope protein
Synonyms:
HBSAG_HBVD3 | S
Type:
n/a
Mol. Mass.:
42772.52
Organism:
Hepatitis B virus
Description:
P03138
Residue:
389
Sequence:
MGQNLSTSNPLGFFPDHQLDPAFRANTANPDWDFNPNKDTWPDANKVGAGAFGLGFTPPHGGLLGWSPQAQGILQTLPANPPPASTNRQSGRQPTPLSPPLRNTHPQAMQWNSTTFHQTLQDPRVRGLYFPAGGSSSGTVNPVLTTASPLSSIFSRIGDPALNMENITSGFLGPLLVLQAGFFLLTRILTIPQSLDSWWTSLNFLGGTTVCLGQNSQSPTSNHSPTSCPPTCPGYRWMCLRRFIIFLFILLLCLIFLLVLLDYQGMLPVCPLIPGSSTTSTGPCRTCMTTAQGTSMYPSCCCTKPSDGNCTCIPIPSSWAFGKFLWEWASARFSWLSLLVPFVQWFVGLSPTVWLSVIWMMWYWGPSLYSILSPFLPLLPIFFCLWVYI
  
Inhibitor
Name:
BDBM520002
Synonyms:
4′-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)-3-oxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl)-2′,3-difluoro-[1,1′-diphenyl]-4-carboxylic acid | US11142527, Example 34
Type:
Small organic molecule
Emp. Form.:
C35H28ClF3N6O5S
Mol. Mass.:
737.147
SMILES:
COC(=O)C1=C(CN2CCN3[C@H](CN(C3=O)c3ccc(c(F)c3)-c3ccc(C(O)=O)c(F)c3)C2)NC(=N[C@H]1c1ccc(F)cc1Cl)c1nccs1 |r,c:4,39|
Structure:
Search PDB for entries with ligand similarity: